NR4A1 and breast carcinoma: Thus, the main goal of this study was to assess the biological outcome and molecular mechanisms of action of CAP in BC cell lines, namely, hormonal-receptor-positive breast cancer cell line MCF7 and triple-negative breast cancer cell line HCC1806.